Russia's largest bank Sber offers up Bitcoin-linked bonds
Russia's largest commercial bank, Sber, launched a Bitcoin-linked bond product that's now trading on OTC markets and may soon be listed on the country's top stock exchange.
Garry Tan Says Founders Must Build With Customers To Compete With Giants Like Salesforce, Oracle: 'You Can't Farm This Out' - Oracle ( NYSE:ORCL ) , Salesforce ( NYSE:CRM )
Y Combinator CEO Garry Tan believes startup founders can learn critical lessons from Palantir Technologies Inc. PLTR forward-deployed engineers ( FDEs ) to compete against enterprise software giants.
ChatGPT User? Former OpenAI Researcher Andrej Karpathy Breaks Down Which Version Works Best For Each Task - Alphabet ( NASDAQ:GOOG ) , Alphabet ( NASDAQ:GOOGL )
On Monday, former OpenAI researcher Andrej Karpathy shared a practical breakdown of ChatGPT's various model versions, helping users understand which one to use based on their specific needs. What Happened: In a post on X, formerly Twitter, Karpathy said many users remain confused about ChatGPT ...
Roche's Tecentriq combined with lurbinectedin shows significant survival benefit in extensive-stage small cell lung cancer
Basel, 3 June 2025 - Roche ( SIX: RO, ROG. OTCQX: RHHBY ) announced today positive results from the Phase III IMforte study of Tecentriq® ( atezolizumab ) in combination with lurbinectedin ( Zepzelca® ) as a first-line maintenance treatment for people with extensive-stage small cell lung cancer ( ...
Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease
Rilzabrutinib granted orphan drug designation in the US for sickle cell disease ...
Addex Convenes Annual General Meeting 2025
Geneva, Switzerland, June 3, 2025 - Addex Therapeutics ( SIX: ADXN and Nasdaq: ADXN ) , a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that its 2025 Annual General Meeting will ...
Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease
Rilzabrutinib granted orphan drug designation in the US for sickle cell disease Fourth orphan drug designation for rilzabrutinib in rare diseases Under regulatory review in the US, the EU, and China in immune thrombocytopenia Paris, June 3, 2025.
argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference - argenx ( NASDAQ:ARGX )
June 3, 2025 Amsterdam, the Netherlands - argenx ( ( Euronext &, NASDAQ:ARGX ) , a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Karl Gubitz, Chief Financial Officer, will participate in a fireside chat at the ...
argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference
June 3, 2025Amsterdam, the Netherlands - argenx ( Euronext & Nasdaq: ARGX ) , a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Karl Gubitz, Chief Financial Officer, will participate in a fireside chat at the ...
This Isn't A 'Great Sign' For Bitcoin, Says Top Currency Trader: 'Whales Are Once Again....' - Strategy ( NASDAQ:MSTR )
Influential trader Justin Bennett raised alarm over Bitcoin's BTC/USD trajectory on Monday as whales increased their short exposure against retail investors. What Happened: Bennett took to X, drawing attention to a bearish signal for the leading cryptocurrency.
